170 filings
Page 8 of 9
6-K
VALN
Valneva SE
2 Jul 21
Valneva Continues Ongoing Discussions with the European Commission for Inactivated COVID-19 Vaccine Candidate
5:25pm
6-K
VALN
Valneva SE
25 Jun 21
Valneva Announces Successful Outcome of its AGM
5:25pm
6-K
VALN
Valneva SE
11 Jun 21
Valneva Completes Recruitment for Phase 3 Lot-to-Lot Consistency Trial of its Chikungunya Vaccine Candidate
5:30pm
6-K
VALN
Valneva SE
4 Jun 21
Valneva Completes Phase 3 Trial Recruitment for its Inactivated COVID-19 Vaccine Candidate
5:30pm
6-K
VALN
Valneva SE
3 Jun 21
Valneva Announces the Availability of Documentation for its Combined General Meeting to be held as a closed meeting
5:30pm
6-K
VALN
Valneva SE
21 May 21
Valneva to Participate in the World’s First COVID-19 Vaccine Booster Trial in the UK
9:58am
6-K
VALN
Valneva SE
14 May 21
Valneva Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Global Offering to $107.6 Million
9:34am
424B4
VALN
Valneva SE
7 May 21
Prospectus supplement with pricing info
4:06pm
CERT
VALN
Valneva SE
6 May 21
Certification of approval for exchange listing
9:43am
EFFECT
VALN
Valneva SE
6 May 21
Notice of effectiveness
12:18am
EFFECT
VALN
Valneva SE
6 May 21
Notice of effectiveness
12:15am
SEC STAFF
VALN
Valneva SE
6 May 21
SEC staff action: Order
12:00am
F-1/A
VALN
Valneva SE
5 May 21
Registration statement (foreign) (amended)
6:07am
8-A12B
VALN
Valneva SE
3 May 21
Registration of securities on exchange
4:03pm
CORRESP
VALN
Valneva SE
3 May 21
Correspondence with SEC
12:00am
CORRESP
VALN
Valneva SE
3 May 21
Correspondence with SEC
12:00am
F-1/A
VALN
Valneva SE
29 Apr 21
Registration statement (foreign) (amended)
6:08am
F-6/A
Citibank,N.A.
23 Apr 21
Registration for ADRs (foreign) (amended)
12:00am
F-1/A
VALN
Valneva SE
21 Apr 21
Registration statement (foreign) (amended)
5:06pm
CORRESP
VALN
Valneva SE
21 Apr 21
Correspondence with SEC
12:00am